The HCT/P Modernization Act of 2024

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 8251 Introduced in House (IH)] <DOC> 118th CONGRESS 2d Session H. R. 8251 To direct the Secretary of Health and Human Services to streamline regulatory oversight of human cell and tissue products, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES May 6, 2024 Mr. Crenshaw (for himself and Ms. Barragan) introduced the following bill; which was referred to the Committee on Energy and Commerce _______________________________________________________________________ A BILL To direct the Secretary of Health and Human Services to streamline regulatory oversight of human cell and tissue products, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``The HCT/P Modernization Act of 2024''. SEC. 2. STREAMLINING REGULATORY OVERSIGHT OF HUMAN CELL AND TISSUE PRODUCTS. (a) Regulatory Classification Inquiries.-- (1) Inquiry described.--An inquiry described in this paragraph is an inquiry-- (A) …